Claims
- 1. A compound selected from the group consisting of all possible racemic, enantiomeric and diastereoisomeric forms of a compound of the formula ##STR52## wherein one of R.sub.1 and R.sub.3 is hydrogen or alkyl of 1 to 6 carbon atoms and the other is selected from the group consisting of --SH, alkylthio of 1 to 6 carbon atoms and phenylthio, R.sub.2 and R.sub.4 are individually selected from the group consisting of hydrogen, halogen, --OH, --CN, --NO.sub.2, sulfo, acyl and acyloxy of a carboxylic acid of up to 12 carbon atoms, alkyl, alkenyl, alkynyl and alkoxy of up to 6 carbon atoms unsubstituted or substituted by a substituent selected from the group consisting of halogen, hydroxyl, amino, mono and dialkylamino where alkyl has 1 to 4 carbon atoms, pyrrolidinyl, morpholinyl, piperidinyl, benzyl, benzyloxy and phenoxy; free, salified, amidified or esterified carboxy with an alkyl of 1 to 4 carbon atoms; pyrrolidinylcarbonyl, morpholinyl-carbonyl, carbamoyl, dialkylcarbamoyl with alkyl of up to 4 carbon atoms and piperidinyl-carbonyl; R' is selected from the group consisting of cyano, free, salified, amidified or esterified carboxy with an alkyl of up to 4 carbon atoms, tetrazolyl, isoxazolyl and --SO.sub.2 --ZC--R.sub.14 C where ZC is selected from the group consisting of --NH--, NH--CO--, --NHCO.sub.2 --, --NH--CO--NH-- and a single bond and R.sub.14 C is selected from the group consisting of methyl, ethyl, propyl, vinyl, allyl, pyridyl, phenyl, benzyl, pyridylmethyl, pyridylethyl, nitropyridyl, pyrimidyl, tetrazolyl, diazolyl, piperidinyl, alkyl-piperidinyl, thiazolyl, alkylthiazolyl, tetrahydrofuranyl and methyltetrahydrofuranyl; and their addition salts with non-toxic, pharmaceutically acceptable acids or bases.
- 2. A compound of claim 1 wherein R.sub.3 is --SH or alkylthio of 1 to 6 carbon atoms or phenylthio.
- 3. A compound of claim 2 wherein and R.sub.1 and R.sub.2 are individually selected from the group consisting of hydrogen, alkyl of up to 6 carbon atoms and free or esterified carboxy with alkyl of up to 4 carbon atoms.
- 4. A compound of claim 2 wherein R.sub.4 is alkyl of up to 6 carbon atoms unsubstituted or substituted by a member selected from the group consisting of hydroxyl, benzyloxy and phenoxy, or is free or esterified carboxy with alkyl of up to 4 carbon atoms.
- 5. A compound of claim 1 wherein R' is tetrazolyl or carboxy.
- 6. A compound of claim 2 wherein R' is tetrazolyl or carboxy.
- 7. A compound of claim 1 selected from the group consisting of 2-(hydroxymethyl)-5-methyl-3-phenylthio-1-��2'-(1H-tetrazol-5-yl)-(1,1'-biphenyl)-4-yl!-methyl!-4-(1H)-pyridone; 2-(hydroxymethyl)-5-butyl-3-phenylthio-1-��2'-(1H-tetrazol-5-yl)-(1,1'-biphenyl)-4-yl!-methyl!-4-(1H)-pyridone; 2-(hydroxymethyl)-5-methyl-3-phenylthio-1-��2'-(carboxyl)-(1,1,-biphenyl)-4-yl!-methyl!-4-(1H)-pyridone; and 2-(hydroxymethyl)-5-butyl-3-phenylthio-1-��2'-(carboxyl)-(1,1,-biphenyl)-4-yl!-methyl!-4-(1H) -pyridone.
- 8. A composition for inhibiting angiotensin II effects comprising an amount of a compound of claim 1 for inhibiting angiotensin II effects and an inert pharmaceutical carrier.
- 9. A composition of for inhibiting angiotensin II effects comprising an amount of a compound of claim 4 for inhibiting angiotensin II effects and an inert pharmaceutical carrier.
- 10. A composition for inhibiting angiotensin II effects comprising an amount of a compound of claim 6 for inhibiting angiotensin II effects and an inert pharmaceutical carrier.
- 11. A composition for inhibiting angiotensin II effects comprising an amount of a compound of claim 7 for inhibiting angiotensin II effects and an inert pharmaceutical carrier.
- 12. A method of treating cardiovascular illnesses in warm-blooded animals comprising administering to warm-blooded animals an amount of a compound of claim 1 sufficient to treat cardiovascular illnesses.
- 13. A method of treating cardiovascular illnesses in warm-blooded animals comprising administering to warm-blooded animals an amount of a compound of claim 4 sufficient to treat cardiovascular illnesses.
- 14. A method of treating cardiovascular illnesses in warm-blooded animals comprising administering to warm-blooded animals an amount of a compound of claim 6 sufficient to treat cardiovascular illnesses.
- 15. A method of treating cardiovascular illnesses i warm-blooded animals comprising administering to warm-blooded animals an amount of a compound of claim 7 sufficient to treat cardiovascular illnesses.
Priority Claims (1)
Number |
Date |
Country |
Kind |
92 01390 |
Feb 1992 |
FRX |
|
PRIOR APPLICATIONS
This application is a continuation of U.S. patent application Ser. No. 446,471 filed May 22, 1995, now abandoned, which is a continuation of U.S. patent application Ser. No. 122,498 filed Sep. 27, 1993, now abandoned, which is a 371 of PCT/FR93/00118, filed Feb. 5, 1993, published as WO93/16049 Aug. 19, 1993.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
3494959 |
Schleppnik et al. |
Feb 1970 |
|
5356911 |
Muller-Gliemann et al. |
Oct 1994 |
|
Foreign Referenced Citations (7)
Number |
Date |
Country |
0324377 |
Jul 1989 |
EPX |
0354495 |
Feb 1990 |
EPX |
0443568 |
Aug 1991 |
EPX |
0445811 |
Sep 1991 |
EPX |
0609053 |
Feb 1979 |
DEX |
0068574 |
Sep 1973 |
JPX |
9119697 |
Dec 1991 |
WOX |
Continuations (2)
|
Number |
Date |
Country |
Parent |
446471 |
May 1995 |
|
Parent |
122498 |
Sep 1993 |
|